PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 2 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $37,000 | – | 34,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 53,000 | $54,000 | 0.11% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 37,000 | $3,760,000 | 0.02% |
| XTX Topco Ltd | 18,463 | $46,000 | 0.02% |
| SANDERS MORRIS HARRIS LLC | 13,000 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |